Clinical trials
Phase 4 trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
1,456 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 9 |
| 2001 | 20 |
| 2002 | 36 |
| 2003 | 61 |
| 2004 | 81 |
| 2005 | 84 |
| 2006 | 109 |
| 2007 | 95 |
| 2008 | 99 |
| 2009 | 92 |
| 2010 | 87 |
| 2011 | 110 |
| 2012 | 64 |
| 2013 | 49 |
| 2014 | 58 |
| 2015 | 65 |
| 2016 | 54 |
| 2017 | 36 |
| 2018 | 32 |
| 2019 | 34 |
| 2020 | 19 |
| 2021 | 33 |
| 2022 | 29 |
| 2023 | 23 |
| 2024 | 19 |
| 2025 | 17 |
| 2026 | 16 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 1,058 |
| Terminated | 162 |
| Unknown status | 120 |
| Recruiting | 60 |
| Withdrawn | 26 |
| Active, not recruiting | 23 |
| Not yet recruiting | 5 |
| Enrolling by invitation | 1 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 90 |
| GlaxoSmithKline | 58 |
| Deutsches Herzzentrum Muenchen | 54 |
| Pfizer | 44 |
| Charite University, Berlin, Germany | 36 |
| Hoffmann-La Roche | 36 |
| Boehringer Ingelheim | 35 |
| Novartis | 35 |
| Bayer | 27 |
| Eli Lilly and Company | 26 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 77 |
| Pulmonary Disease, Chronic Obstructive | 51 |
| Atrial Fibrillation | 50 |
| Coronary Artery Disease | 46 |
| Asthma | 30 |
| Coronary Disease | 30 |
| Diabetes Mellitus | 30 |
| Heart Failure | 30 |
| Schizophrenia | 30 |
| Hypertension | 25 |
Trials
Showing 1 to 25 of 1,456. Each trial links to its page on Pharma Observatory.
1,356 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.